Morgan Stanley lowered the firm’s price target on Walgreens Boots Alliance to $9 from $13 and keeps an Underweight rating on the shares. While expectations were not overly high, Walgreens lowered its FY24 EPS guidance and there is some debate around visibility on the turnaround and Morgan Stanley sees further downside from here, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Who Owns Walgreens Boots Alliance Stock (WBA)?
- Walgreens Boots Alliance Inc. Reports Earnings: Did it Beat Estimate Forecasts?
- WBA Earnings: Walgreens Crumbles on Lowered Outlook
- Walgreens Boots Alliance Fiscal Quarter Results Webcast
- Walgreens Boots Alliance sees achieving $1B projected cost savings in 2024